UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000006643 |
|---|---|
| Receipt number | R000007852 |
| Scientific Title | WJOG6510G : Randomized phase II study of panitumumab + irinotecan versus cetuximab + irinotecan in Patients Wild-Type KRAS Metastatic Colorectal Cancer Following Treatment with Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy |
| Date of disclosure of the study information | 2011/11/01 |
| Last modified on | 2019/05/23 11:27:23 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/11/01 15:21:43 | ||
| 2 | Update | 2012/05/01 09:14:12 | Recruitment status |
|
| 3 | Update | 2014/09/10 09:11:58 | Email Name of person sending information Name of person sending information |
|
| 4 | Update | 2014/09/16 18:40:28 | Recruitment status |
|
| 5 | Update | 2016/11/24 17:01:33 | Key secondary outcomes Key secondary outcomes |
|
| 6 | Update | 2017/06/01 09:23:35 | Recruitment status |
|
| 7 | Update | 2019/05/23 11:27:23 | Recruitment status Date of IRB Anticipated trial start date Last follow-up date |
